drugset / Trial / NCT00788788

Heliox in Experimental Upper Airway Obstruction

NCT00788788

Phase 1/2 Completed 44 enrolled University of Witten/Herdecke
RandomizedCrossoverQuadruple-blindTreatment

Summary

Currently it is common medical wisdom that HELIOX (mixture of Helium in Oxygen) with a fraction of Helium below 60% is not effective in reducing airway obstruction. The investigators test the hypothesis that HELIOX with a fraction of Helium below 60% is still effective in relieving airway obstruction in a double-blind, randomized and controlled clinical PoC study with experimental upper airway obstruction.

Timeline

Start
2007-11
Primary completion
2007-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heliox Other / unclassified 25 % Inhaled
Comparator Heliox Other / unclassified 50 % Inhaled
Comparator Heliox Other / unclassified 75 % Inhaled

Indications

No indication recorded.